ArticleEJHaem2025

Follow-Up of 3-Year Luspatercept Treatment in a Transfused ß-Thalassemia Patient. Bone Marrow: An Undervalued Iron Store.

Matthias Bleeke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.